Sale!

Replica Osimertinib EGFR-TKI for NSCLC Treatment

Original price was: $647.00.Current price is: $488.00.

Osimertinib Targeted Lung Cancer Drug, Third Generation EGFR-TKI, irreversible, treats NSCLC with EGFR Ex19Del or EGFR L858R mutations, effective against central nervous system metastases,

SKU: SKU67ENEAOP9 Category:
Guaranteed Safe Checkout

Osimertinib Targeted Lung Cancer Drug, Third Generation EGFR-TKI, irreversible, treats NSCLC with EGFR Ex19Del or EGFR L858R mutations, effective against central nervous system metastases,

Scroll to Top